Philadelphia is a Jordanian pharmaceuticals company specialized in development, manufacturing and marketing of human pharmaceutical products of different therapeutic categories. Philadelphia was established in 1993 by the successful cooperation and integration of qualified technical experts with a passion of doing level best to enable the company to produce quality products that all can trust. Philadelphia was approved from MOH and took part in pharmaceutical industry in 1997. Since that time, the company focuses on covering local market demand and looking for future expansion through potential large export markets of the Middle East and North Africa. Philadelphia operates in total compliance with cGMP (Current Good Manufacturing Practice) and approved by JFDA in addition to approval of health authorities of different countries in the region. This process is achieved by a high-tech quality assurance and quality control laboratories equipped with various required equipments and instruments, and technically operated by a number of highly qualified and well trained employees.